Geoffrey Thomas Yarranton
Nessuna posizione attualmente
Storia della carriera di Geoffrey Thomas Yarranton
Precedenti posizioni note di Geoffrey Thomas Yarranton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Celscia Therapeutics, Inc.
 Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Fondatore | 01/01/2004 | 01/01/2004 |
| Presidente | - | 01/01/2004 | |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Direttore Tecnico/Scientifico/R&S | 02/10/2012 | - |
| Corporate Officer/Principal | - | 02/10/2012 | |
| DELTAGEN INC. | Corporate Officer/Principal | 01/05/2002 | - |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Corporate Officer/Principal | - | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - | - |
| HUMANIGEN, INC. | Direttore/Membro del Consiglio | 01/10/2006 | 02/10/2012 |
| Direttore Tecnico/Scientifico/R&S | 01/10/2006 | - |
Formazione di Geoffrey Thomas Yarranton
| University of Leicester | Undergraduate Degree |
| The National Institute For Medical Research | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 4 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| HUMANIGEN, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Commercial Services |
